Skip to main content
Caplight Logo









RJH Biosciences

RJH Biosciences

Private
EdmontonHealthcare & Life Scienceshttps://rjhbiosciences.com

Last Round

Accelerator

Apr 7, 2021

Total Funding Raised

$205,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RJH Biosciences operates in Healthcare & Life Sciences and is based in Edmonton. Its latest recorded funding round was an Accelerator round in April 2021.

RJH Biosciences is a biotechnology company that develops novel transfection reagents and nucleic acid delivery systems for biomedical research and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

RJH Biosciences Comparables

Compare RJH Biosciences with similar companies based on industry and business-model similarity.

RJH Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altogen Biosystems
88%
OZ Biosciences
83%
Biontex Laboratories GmbH
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

RJH Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 7, 2021
GrantNov 14, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

RJH Biosciences Investors

Notable investors and investment history

RJH Biosciences investors
InvestorRounds
Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 1530% MoM, reaching 8.2K.

  • May 16, 2026

    Monthly visitors grew 222% MoM, reaching 4.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

RJH Biosciences Filings

Explore SEC and related filing metadata, where available.

RJH Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about RJH Biosciences's valuation, stock price, and market status.

Is RJH Biosciences a public or private company?

RJH Biosciences is a private company.

What is the current stock price of RJH Biosciences?

RJH Biosciences is a private company, so its shares have no public market price. Caplight tracks RJH Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RJH Biosciences worth (valuation)?

Valuation information for RJH Biosciences is not publicly available.

Can I buy RJH Biosciences stock?

RJH Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RJH Biosciences's last funding round?

RJH Biosciences's most recent funding round was Accelerator on April 7, 2021.

Who are the main investors in RJH Biosciences?

Key investors in RJH Biosciences include Gates Foundation.

Will RJH Biosciences IPO soon?

No public IPO plans have been announced for RJH Biosciences.

How can I track RJH Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in RJH Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersEdmonton
Employee Range7
Year Founded2016
Last FundingApr 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?